Carbetocin
Indications
Registered South African indications:
- Postpartum uterine atony
Cautions
Contraindications
- Hypersensitivity to the active ingredient or any of its excipients
- Hypersensitivity to oxytocin
- Pregnancy
- Renal impairment
- Hepatic impairment
- Induction of labour
- Pre-eclampsia
- Eclampsia
- Serious cardiovascular disorders
- Epilepsy
Cautions
- Breastfeeding
- Use before delivery of infant
- Patients also receiving large volumes of intravenous fluids
- Migraine
- Asthma
- Cardiovascular disease
- Gestational diabetes mellitus
- Vaginal delivery
Adult dosage
Forms avail. in SA and covered in this monograph: inj
Postpartum uterine atony
- Post caesarean section
- IV: 100μg, given over 1min, immediately after baby delivered
It should be given as soon as possible after delivery, preferably before removal of the placenta
Paediatric dosage
Not established for use in children
Special populations
Pregnancy
- Contraindicated
- Carbetocin is contraindicated during pregnancy and must not be used for the induction of labour
Breastfeeding
- Caution
- No significant effects on milk let-down have been reported during clinical trials. Small amounts of carbetocin have been shown to pass from plasma into breast milk of breastfeeding women. The small amounts transferred into colostrum or breast milk after a single injection of carbetocin, and subsequently ingested by the infant are assumed to be degraded by enzymes in the gut
Renal Impairment
- No dose adjustment recommended (single-dose use)
- Document renal function (CrCl/eGFR) prior to use
Hepatic Impairment
Elderly
Porphyria Information
Drugs in Sport
- Permitted - No warnings
Adverse reactions
Central Nervous System Disorders
- Headache
- Tremor
- Dizziness
Cardiovascular Disorders
- Hypotension
- Flushing
Respiratory Disorders
- Chest pain
- Dyspnoea
Gastrointestinal Disorders
- Nausea and vomiting
- Abdominal pain
- Metallic taste
Musculoskeletal Disorders
- Back pain
Skin and Subcutaneous Tissue Disorders
- Pruritus
Immune, Blood and Lymphatic System Disorders
- Anaemia
- Chills
Others
- Feeling of warmth
Interactions
- Vasoconstrictors
- Ergot-alkaloids
- Prostaglandins
- Halothane
- Cyclopropane
Monitoring
- Blood pressure
- Postpartum bleeding
Mechanism of action
Carbetocin binds to oxytocin receptors located in uterine smooth muscle producing rhythmic uterine contractions characteristic to deliver, as well as increasing both the frequency of existing contractions and uterine tone. It enhances uterine involution early in postpartum.
Dosage forms
- Injection
Formulation
Injection (per ml) 100μg
- Pabal (Ferring) originator
References
1. SAMF_12th edition_Page 221 2. SmPC: Pabal 100 micrograms in 1ml solution for injection, Ferring Pharmaceuticals Ltd:Last updated on eMC: 30 May 2018; Downloaded online 21 Feb 2019 [https://www.medicines.org.uk/emc/medicine/17274] 3. https://drive.google.com/drive/folders/1p9f7OXNgBnS6-xDesJh6wMZiV78OR-Al (20/06/2013_Ferring_Pabal_100mcg/ml_inj) 4. U2D: Carbetocin (United States: Not available): Drug information; Uptodate; Downloaded online 21 Feb 2019 [https://www.uptodate.com/contents/carbetocin-united-states-not-available-drug-information?source=search_result&search=Carbetocin&selectedTitle=1~6] 5. NAPOS The Drug Database for Acute Porphyria: H01BB03 Carbetocin; Accessed online 21 Feb 2019 [http://www.drugs-porphyria.org/languages/UnitedKingdom/s3.php?l=gbr&atc_code=H01BB03] 6. South African Institute for Drug-Free Sport: Pabal; Accessed online 21 Feb 2019 [http://www.drugfreesport.org.za/online-medication-check/] 7. Dr Irhuma's updates. Updated 2 May 2020 [https://trello.com/c/WN3Gyq4L/244-carbetocin-inj-renal-and-hepatic-impairment-recommendations] 8. SmPC:Pabal 100 micrograms in 1ml solution for injection, Ferring Pharmaceuticals Ltd: Last updated 20 Dec 2019. Downloaded 2 May 2020 [https://www.medicines.org.uk/emc/medicine/17274]
Brands & products
1 product · stale NAPPI snapshot · refreshed 5/29/2026 · 158 days oldinjectionGeneric· 1 product
from R413.32/unit| Product | Strength | Pack | Sched | SEP | Unit | Disp fee | NAPPI |
|---|---|---|---|---|---|---|---|
| Pabal solution for injection 1ml | 100 mcg/ml | 1 | S3 | R2066.58 | R413.32 | R328.08 | 718912001 |
- Pabal
Medical aid coverage
data not yet integrated- Comprehensive Series—
- Executive Plan—
- KeyCare Series—
- Priority Series—
- Saver Series—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- BonClassic—
- BonComprehensive—
- BonEssential—
- BonFit Select—
- BonSave—
- BonStart—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- Beryl—
- Emerald—
- Onyx—
- Ruby—
- Sapphire—
- Tanzanite One—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- Aquarium Option—
- Efficiency Option—
- Marine Option—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.